Expanding Treatment Portfolio Greenbrook TMS Centers focus on advanced non-invasive mental health treatments like NeuroStar TMS Therapy and SPRAVATO nasal spray, indicating a demand for innovative, FDA-cleared therapies which could open opportunities for supply or partnership in cutting-edge medical devices and pharmaceuticals.

Access and Accessibility With locations across the United States and a mission to make mental health care more accessible, Greenbrook presents potential sales opportunities for telehealth solutions, digital health platforms, and patient engagement tools that can support rapid scalability and reach in underserved areas.

Financial Growth and Investment Despite recent stock delisting and stock price volatility, Greenbrook has secured significant funding through debt offerings and a registered direct offering, signaling ongoing financial activity and potential openness to strategic investments or financial services in the healthcare sector.

Regulatory and Market Challenges Recent delisting from NASDAQ highlights the company's regulatory and market challenges, creating opportunities for compliance solutions, investor relations technology, or consulting services that can help stabilize and optimize their corporate governance and market positioning.

Leadership Expansion The appointment of new CFO and board members suggests a period of strategic realignment and growth, presenting opportunities for executive-level engagement, consultancy on scaling operations, and solutions tailored to strengthen leadership and governance amid expansion efforts.